Microbiology

  1. Comparative Genomics and Integrated Network Approach Unveiled Undirected Phylogeny Patterns, Co-mutational Hotspots, Functional Crosstalk and Regulatory Interactions in SARS-CoV-2

    1. Vipin Gupta
    2. Shaiza Haider
    3. Mansi Verma
    4. Nirjara Singhvi
    5. Kalaiarasan Ponnusamy
    6. Md. Zubbair Malik
    7. Helianthous Verma
    8. Roshan Kumar
    9. Utkarsh Sood
    10. Princy Hira
    11. Shiva Satija
    12. Yogendra Singh
    13. Rup Lal

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  2. Engineered human mesenchymal stem cells as new vaccine platform for COVID-19

    1. Junhua Liu
    2. Huping Jiao
    3. Xiushan Yin

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  3. Rapid Inactivation of SARS-CoV-2 by Silicon Nitride, Copper, and Aluminum Nitride

    1. Giuseppe Pezzotti
    2. Eriko Ohgitani
    3. Masaharu Shin-Ya
    4. Tetsuya Adachi
    5. Elia Marin
    6. Francesco Boschetto
    7. Wenliang Zhu
    8. Osam Mazda

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  4. Proteotyping SARS-CoV-2 Virus from Nasopharyngeal Swabs: A Proof-of-Concept Focused on a 3 Min Mass Spectrometry Window

    1. Duarte Gouveia
    2. Guylaine Miotello
    3. Fabrice Gallais
    4. Jean-Charles Gaillard
    5. Stéphanie Debroas
    6. Laurent Bellanger
    7. Jean-Philippe Lavigne
    8. Albert Sotto
    9. Lucia Grenga
    10. Olivier Pible
    11. Jean Armengaud

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  5. Identification of a critical horseshoe-shaped region in the nsp5 (Mpro, 3CLpro) protease interdomain loop (IDL) of coronavirus mouse hepatitis virus (MHV)

    1. Benjamin C. Nick
    2. Mansi C. Pandya
    3. Xiaotao Lu
    4. Megan E. Franke
    5. Sean M. Callahan
    6. Emily F. Hasik
    7. Sean T. Berthrong
    8. Mark R. Denison
    9. Christopher C. Stobart

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  6. Drug repurposing screens reveal FDA approved drugs active against SARS-Cov-2

    1. Mark Dittmar
    2. Jae Seung Lee
    3. Kanupriya Whig
    4. Elisha Segrist
    5. Minghua Li
    6. Kellie Jurado
    7. Kirandeep Samby
    8. Holly Ramage
    9. David Schultz
    10. Sara Cherry

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  7. Evaluation of the performance of SARS-CoV-2 serological tools and their positioning in COVID-19 diagnostic strategies

    1. Aurelie Velay
    2. Floriane Gallais
    3. Ilies Benotmane
    4. Marie Josée Wendling
    5. François Danion
    6. Olivier Collange
    7. Jérôme De Sèze
    8. Catherine Schmidt-Mutter
    9. Francis Schneider
    10. Pascal Bilbault
    11. Ferhat Meziani
    12. Samira Fafi-Kremer

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  8. Variant analysis of SARS-CoV-2 genomes in the Middle East

    1. Khalid Mubarak Bindayna
    2. Shane Crinion

    Reviewed by ScreenIT

    2 evaluationsAppears in 1 listLatest version Latest activity

  9. In silico and in vitro evaluation of imatinib as an inhibitor for SARS-CoV-2

    1. Nirmitee Mulgaonkar
    2. Haoqi Wang
    3. Samavath Mallawarachchi
    4. Daniel Růžek
    5. Byron Martina
    6. Sandun Fernando

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  10. Polymorphism and Selection Pressure of SARS-CoV-2 Vaccine and Diagnostic Antigens: Implications for Immune Evasion and Serologic Diagnostic Performance

    1. Eric Dumonteil
    2. Claudia Herrera

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity
Previous Page 50 of 246 Next